Literature DB >> 17720504

Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.

Asha Singh1, Geetha Kandimala, Richard B Dewey, Padraig O'Suilleabhain.   

Abstract

Three hundred patients with Parkinson's disease taking dopamine agonists were surveyed for the presence of compulsions. Fifty-eight reported active compulsions which had developed after initiation of dopamine agonists. These included 25 with sexual compulsions and 28 with self-described compulsive gambling, of whom 17 met criteria for pathologic gambling. Males were over-represented. Patients with any compulsion and those with pathologic gambling were about 6 years younger than those without compulsions. These behavioral problems were not associated with an individual dopamine agonist, nor dose or duration, nor concomitant levodopa. Follow-up of the pathologic gamblers 1 year after intervention, which was cessation of the dopamine agonist in most cases, found ongoing but controlled gambling in five and complete cessation within 4 months in the remainder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720504     DOI: 10.1016/j.jocn.2007.01.009

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  18 in total

1.  A case of compulsive behaviors observed in a restless legs syndrome patient treated with a dopamine agonist.

Authors:  Rachel E Salas; Richard P Allen; Christopher J Earley; Charlene E Gamaldo
Journal:  Sleep       Date:  2009-05       Impact factor: 5.849

Review 2.  Impulsive and compulsive behaviors in Parkinson's disease.

Authors:  B B Averbeck; S S O'Sullivan; A Djamshidian
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

3.  Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?

Authors:  Atbin Djamshidian; Sean S O'Sullivan; Yanosh Sanotsky; Stephen Sharman; Yuriy Matviyenko; Thomas Foltynie; Rosanna Michalczuk; Iciar Aviles-Olmos; Ludmyla Fedoryshyn; Karen M Doherty; Yuriy Filts; Marianna Selikhova; Henrietta Bowden-Jones; Eileen Joyce; Andrew J Lees; Bruno B Averbeck
Journal:  Mov Disord       Date:  2012-07-20       Impact factor: 10.338

4.  Dopaminergic Medication in Parkinson's Disease and Problem Gambling.

Authors:  Jacqueline Olley; Alex Blaszczynski; Simon Lewis
Journal:  J Gambl Stud       Date:  2015-09

Review 5.  Impulse control disorders in Parkinson's disease.

Authors:  Ana Marques; Franck Durif; Pierre-Olivier Fernagut
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

6.  Longitudinal analysis of impulse control disorders in Parkinson disease.

Authors:  Jean-Christophe Corvol; Fanny Artaud; Florence Cormier-Dequaire; Olivier Rascol; Franck Durif; Pascal Derkinderen; Ana-Raquel Marques; Frédéric Bourdain; Jean-Philippe Brandel; Fernando Pico; Lucette Lacomblez; Cecilia Bonnet; Christine Brefel-Courbon; Fabienne Ory-Magne; David Grabli; Stephan Klebe; Graziella Mangone; Hana You; Valérie Mesnage; Pei-Chen Lee; Alexis Brice; Marie Vidailhet; Alexis Elbaz
Journal:  Neurology       Date:  2018-06-20       Impact factor: 9.910

Review 7.  Spectrum of addictions in Parkinson's disease: from dopamine dysregulation syndrome to impulse control disorders.

Authors:  Roberto Ceravolo; Daniela Frosini; Carlo Rossi; Ubaldo Bonuccelli
Journal:  J Neurol       Date:  2010-11       Impact factor: 4.849

8.  Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease.

Authors:  Daniel Weintraub; Staci Hoops; Judy A Shea; Kelly E Lyons; Rajesh Pahwa; Erika D Driver-Dunckley; Charles H Adler; Marc N Potenza; Janis Miyasaki; Andrew D Siderowf; John E Duda; Howard I Hurtig; Amy Colcher; Stacy S Horn; Matthew B Stern; Valerie Voon
Journal:  Mov Disord       Date:  2009-07-30       Impact factor: 10.338

Review 9.  Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.

Authors:  Emke Maréchal; Benjamin Denoiseux; Ellen Thys; David Crosiers; Barbara Pickut; Patrick Cras
Journal:  J Neurol       Date:  2014-05-14       Impact factor: 4.849

10.  Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia.

Authors:  Andrew J Holman
Journal:  J Gambl Stud       Date:  2009-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.